Small-animal models of lentivirus transmission have repeatedly demonstrated transmission by cell-associated virus via vaginal, rectal, and oral routes. The earliest experiments were in the cat/feline immunodeficiency virus model, followed a decade later by successful vaginal transmission of cell-associated human immunodeficiency virus (HIV) in mice bearing transplanted human immune cells. After early unsuccessful attempts at cellassociated transmission in nonhuman primates, renewed investigation in diverse primate models has now confirmed the findings from the cat and humanized mouse models. Improvements in humanized mouse models have made them the preferred small-animal models to study HIV mucosal transmission. They provide complementary systems to nonhuman primate models to aid in the elucidation of the many remaining questions on the mechanism of and means to prevent both cell-associated and cell-free HIV transmission across mucosal barriers.
Small-animal models have been especially prominent in the study of transmission by infected cell inocula: early experiments modeling vaginal and rectal lentivirus transmission in the cat/FIV model were successful when infected cells were used as the viral inoculum [2, 3] . Soon thereafter, attempts were made to transmit via infected cells in the rhesus macaque model and were unsuccessful [4, 5] . This result in the primate model raised skepticism regarding the importance of cell-associated transmission in humans and reduced interest in and support for its investigation. However, subsequent experiments have documented successful transmission in multiple primate species [6] [7] [8] . This review describes research on cell-associated mucosal lentivirus transmission in small-animal models, including the FIV-cat, the SIV/ SHIV-macaque, and the HIV-humanized mouse models. Table 1 compares the small-animal models and primate models that have successfully demonstrated cell-associated mucosal lentivirus transmission. related feline species and has broad genetic diversity, with subtypes classified into subtypes A-E, each with particular variable geographic distributions [12] . Further diversity is generated by recombination between subtypes. Instead of CD4, FIV uses CD134, also known as OX40, as its primary receptor and uses a single coreceptor, CXCR4 [13] . CD134/OX40 is a member of the tumor necrosis factor superfamily [14] and is present on activated CD4 + T cells but absent on resting T cells. Although FIV does not use CD4 as a receptor, the cellular tropism of primary isolates in feline cells is similar to the tropism of HIV in human cells. This tropism includes mitogen-activated peripheral blood mononuclear cells (PBMCs), macrophages, dendritic cells, and T-cell lines [15] . Unlike HIV, FIV can also infect a subset of CD8 + T cells and, occasionally, B cells [15] .
Like HIV, FIV infection is often followed by an initial acute syndrome with fever, lymphadenopathy, neutropenia, high viral replication, and a highly active but largely ineffective immune response and is then followed by an asymptomatic period [11] . Although natural FIV infection is less pathogenic than HIV infection and many FIV-infected cats display no symptoms for years or throughout their lives, FIV often progresses to an active immunodeficiency disease [11] . Both cell-free and cell-associated virus are present in the semen of infected male cats [16, 17] and in vaginal secretions [15] . Semen from FIV-infected males has been shown to infect female cats through artificial insemination [18] .
FIV thus offers the opportunity to study a lentivirus with important similarities to HIV in its natural outbred host and to challenge with diverse naturally occurring viral strains. A rich variety of research has been published covering FIV molecular biology, pathogenesis, natural history, immunology, and experimental transmission. Most pertinent here are studies of cellassociated transmission. The FIV-cat model was used for the first demonstration that a lentivirus could be transferred across mucosal surfaces by infected cells and to document mucosal transmission by the vaginal, rectal, and oral routes [2] . The model was also the first to demonstrate blocking of cell-associated vaginal and rectal transmission by a candidate topical microbicide [2] . Cell-associated vaginal and rectal FIV transmission was soon confirmed by others [3, 19] , with an estimated animal median infectious dose (ID 50 ) with the infected T-cell inoculum on the order of 10 4 median tissue culture infectious doses (TCID 50 ) [19] . Mucosal transmission by cell-free FIV was also documented by both of these laboratories [3, 19] .
HUMANIZED MOUSE MODELS
The development of so-called humanized mice-that is, immunodeficient mice that have received human immune cells transplants-has provided a means to study HIV in vivo rather than relying on related surrogate viruses [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . Because of their immunodeficiency, these mice tolerate the transplanted foreign immune cells, which can thrive in the mice for many months. In the most realistic models, the human immune cells can be said to constitute an engrafted functioning human immune system. These models have been used in diverse studies, including pathogenesis, immunology, drug and gene therapy, and parenteral and mucosal transmission, and to evaluate topical and systemic microbicides [24] [25] [26] .
The first humanized mouse model that was developed and the first used to study mucosal transmission of HIV was the hu-PBL-SCID model [20, 21] . Here, PBMCs from human blood are injected intraperitoneally into mice with severe combined immunodeficiency (SCID) and establish viable colonization with human immune cells. This model was used by two groups to demonstrate vaginal transmission of HIV by infected cultures of mitogen-stimulated human PBMCs. Mice were pretreated with Depo-Provera to increase susceptibility and, importantly, to dependably synchronize the vaginal epithelium of all the animals in a uniform diestrus-like state. Vaginally deposited infected cells could transmit HIV to the mice [20, 21] , with an approximate vaginal ID 50 on the order of 10 3 infected cells [21] .
Entry of fluorescently labeled, vaginally deposited cells into vaginal tissues and regional lymph nodes was documented [20] and is likely the means of transmission of infection into the mice. As has been observed in so-called founder viruses detected early after human transmission, a viral strain known to use coreceptor CCR5 (HIV-1 Ba-L ) was transmitted with greater efficiency than a CXCR4-using strain (HIV-1 MN ) [21] . Free virus was found to have very low transmission efficiency in this model, probably because of the absence of engrafted human cells in the female reproductive tract [21] . Although a limitation, this lack of transmission by free virus has provided the most clear-cut evidence in any model that infected cells can transmit infection directly, eliminating the potential alternative that the cells transmitted by release of free virus in the vaginal lumen. The in vivo efficacies of several topical microbicides (betacyclodextrin [21] , an acidifying gel [27] , and the reverse transcriptase inhibitor dapivirine [28] ) have been tested in this model. The huPBL-SCID model has the advantage of simplicity: the transplanted human PBMCs are easily obtained, the transplantation procedure is a straightforward (intraperitoneal injection of adult mice), and the mice are ready to use very soon after transplantation. Nevertheless, the model has important disadvantages, including limited engraftment of all but T-cell lineages, a substantial incidence of graft versus host disease, and a chronic high level of immune activation of the engrafted human cells [29] . And, presumably due to low levels of peripheral transplant engraftment, some laboratories have reported low efficiency of vaginal transmission of HIV, even by an infected cell inoculum [30] . For these reasons, newer humanized mouse models have superseded this pioneering model.
The newer humanized mouse models [29, 31, 32 ] more completely mimic a functional human immune system with engraftment of all major lineages of immune cells (T cells, B cells, monocyte/macrophages, dendritic cells, and natural killer cells) and, in one model (the bone marrow-liver-thymus [BLT] model) [31, 32] , have the capability of generating primary human immune responses. Important to transmission experiments, the transplanted human cells are distributed far more widely, with engraftment in lymph nodes, gastrointestinal tract, and genital tract tissue [29, 31, 32] . Moreover, the efficiency of engraftment and susceptibility to HIV infection in these models can be substantially improved by careful selection of immunodeficient mouse strains, such as NOD-scid IL-2Rγ −/− [33] . These models have largely superseded the hu-PBL-SCID model for the study of HIV transmission. Among these new models, the dominant models used in HIV transmission studies are the BLT model [31, 32] and the hu-HSC model [29] .
In the BLT model [31, 32] , the transplantation procedure involves coimplantation of human fetal liver and thymic tissue under the kidney capsule of irradiated adult NSG-immunodeficient mice, plus additional CD34 + human stem cells (HSCs) administered intravenously. The implantation of thymic tissue permits human T-cell education and restriction. The stem cells populate the mouse widely, including the lymph nodes, gastrointestinal tract, and female reproductive tract. The BLT model thus appears to provide the most highly functioning human immune system among the available humanized mouse models. The model has been used to study infection with cell-free HIV in the vagina [32] and rectum [22, 32] and has demonstrated the efficacy of several systemic and topical antiretroviral microbicides to block infection, with dosing similar to human regimens [31, 32] . Recently, a preliminary report described successful use of the BLT model to study vaginal transmission by cellassociated HIV and the efficacy of preventive microbicides [34] . S656 • JID 2014:210 (Suppl 3) • Moench A reduced efficacy of topical tenofovir against a cell-associated inoculum was reported, in contrast to its high efficacy in preventing cell-free virus transmission [34] .
In an alternative humanized mouse model, the hu-HSC model, the transplant is delivered by injection of human stem cells (HSCs) from fetal liver or cord blood into the livers of irradiated newborn RG, NOG, or NSG mice, with NSG mice now preferred because of greater engraftment efficiency [29] . As with the BLT model, the hu-HSC model has been used to study vaginal and rectal transmission with cell-free virus [29, 35, 36] and to assess systemic and topical microbicide efficacy [37, 38] . Recently, the model has also been used to demonstrate the vaginal transmission of cell-associated HIV-2 (Dr Ramesh Akkina, Colorado State University, personal communication).
In both the BLT and hu-HSC vaginal transmission models, mice are not pretreated with progestins, which, in one respect, is an important advantage in that this eliminates a nonphysiological perturbation. However, without progestin pretreatment, the mouse 5-day estrus cycle is continuously altering vaginal epithelial thickness and surface character, yielding, for example, many layers of sloughing dead squamous epithelial cells at estrus, compared with a 1-or 2-cell layer of living surface cells during diestrus. It is likely that other hormone-induced changes, such as those involving immune cell function, also vary with the stage of the estrus cycle. Even in primates, in which cycling results in somewhat less dramatic epithelial changes than those observed in mice, dramatic alterations in susceptibility to vaginal challenge with SIV in naturally cycling pigtailed macaques has been observed [39] . And an examination of cycle-related epithelial thickness and level of keratinization in rhesus versus pigtailed macaques provided evidence that these factors may explain the substantially greater susceptibility of pigtail versus rhesus macaques to vaginal SIV challenge [40] . In light of these findings, studies comparing groups of mice that may be in different phases of the cycle may vary in infection rate due to intrinsic cycle-related susceptibility rather than solely on the basis of their assigned treatment. The interpretation of results in these models when this variable is uncontrolled would be expected to be even more problematic when small group sizes are used and without repeated experiments to test for the replicability of results.
CONFIRMATION IN NONHUMAN PRIMATES OF CELL-ASSOCIATED TRANSMISSION OBSERVED IN SMALL-ANIMAL MODELS
The first attempts to transmit SIV via an infected cell inoculum in rhesus macaques were unsuccessful [4, 5] . In light of the observed transmission in the cat and humanized mouse models and of the results in later primate models, the reasons for lack of transmission in these early experiments are not clear. Possibilities may include factors such as the particular SIV strain used for challenge, incomplete recovery of relevant inoculum cell functions after cryopreservation (eg, migratory functions), the stage of estrus cycle at inoculation [39] , and the relatively small maximum number of infected cells used. Since the rhesus macaque model was the dominant transmission model, this negative result inhibited the acceptance that cell-associated transmission occurs, as well as its continued investigation, since the primate model was considered more definitive than the early work in the cat and humanized mouse models [2, 3, [19] [20] [21] 28] .
However, in contrast to the negative results in the initial attempts, later investigations have repeatedly demonstrated cellassociated mucosal transmission in diverse primate models. A study in chimpanzees successfully transmitted HIV via instillation just inside the cervical os of a remarkably low dose of several hundred HIV-1 LAI(IIIB) -infected cryopreserved chimpanzee PBMCs [6] . Subsequently, a model to assess transmission of cell-associated SIV (PBMCs infected in vitro with SIV Mac239 ) showed high vaginal transmission efficiency in cynomolgus macaques with detergent-induced vaginal ulcerations [7] . Importantly, the control animals without ulcerations were also highly susceptible, with transmission documented with as few as 2 sequential vaginal inoculations each with <10 infected PBMCs. Notably, these investigators prepared and used the SIV-infected PBMC inoculum fresh to avoid changes from cryopreservation and thawing that might interfere with motility or other functions required for transmission [7] .
More recently, Sallé et al have established a cell-associated vaginal transmission model in cynomolgus macaques [8] . The inoculum was more diverse in cell type than previous models, having been produced using spleen cells from an animal acutely infected with SIV. Thus, unlike previous inocula that comprised T cells almost entirely, the inoculum in this model also contained mature macrophages, albeit in small numbers (2% were CD14 + monocyte/macrophages). This is important in light of the observation that the semen from HIV-infected men is markedly depleted of CD4 + T cells and, thus, that the potential HIV-transmitting cells present in the semen of infected men are generally dominated by macrophages [41] . The vaginal ID 50 for the spleen cell inoculum was quite low, at approximately 4000 TCID 50 , an amount of infectious cells shown to be within the range present in human semen [42] .
POSSIBLE MECHANISMS OF CELL-ASSOCIATED TRANSMISSION
Entry of labeled infected cells across the vaginal epithelium and into regional and distant lymph nodes has been documented in the hu-PBL-SCID [10] and in 2 macaque models [8, 42] . Contact with target cells in the epithelium, subepithelium, or lymph nodes could transfer virus by direct cellular contact or by release of free virus. In many of these experiments, the epithelium had been altered with progestin pretreatment or detergent-induced ulcerations, but in one report [7] , several cases of transmission occurred with no epithelial compromise present. Moreover, cell entry across the progestin-thinned mouse or monkey vagina arguably models transmission across endocervical epithelium, with its single-cell thickness and living cells on the surface. And, pertinent to the relevance of entry in the ulcerated model [43] , similar lesions are present in ulcerative sexually transmitted infections that are known to potently enhance susceptibility to HIV acquisition and may be responsible for a high proportion of HIV transmissions [44] . Other mechanisms of cell-associated transmission may also play a role, such as cellmediated transcytosis across epithelial cells or transfer of virus from infected cells to intraepithelial target cells via viral synapse [45] .
UNANSWERED QUESTIONS ON THE MECHANISM AND PREVENTION OF CELL-ASSOCIATED TRANSMISSION ACCESSIBLE TO STUDY IN SMALL-ANIMAL MODELS
Perhaps a reason cell-associated transmission has been less studied than cell-free virus transmission is the additional complicating permutations that are inherent with an infected cell inoculum. Although these are indeed complications, they are also opportunities to reach a more detailed understanding of the mechanisms of transmission and their influence on the success of preventive strategies. Many inoculum factors beyond the identity of the viral isolate may influence cell-associated transmission efficiency, such as the cell type (eg, T cell vs macrophage), the activation state of the inoculum cells, and the consequences of cryopreservation and recovery of frozen cellular inoculum stocks or, alternatively, the difficulty in standardizing or characterizing freshly prepared cellular inocula. Likewise, the state of the target epithelium of the recipient animals will affect susceptibility: for example, the presence or absence of chemotactic signals influencing inward migration of inoculum cells is a highly plausible factor likely to alter the efficiency of transmission, but as yet it has been minimally studied. Moreover, the hormonal state of the female reproductive tract, including after progestin pretreatment, or the effect of the natural estrus cycle is likely to alter susceptibility. The effect of the natural estrus cycle in these models has thus far not been studied and is likely influencing susceptibility and affecting the results of comparative experiments.
Although work with animal models has the potential to explore the relative importance of the cell-associated versus cellfree routes of infection, this has not yet been accomplished. The threshold doses of cellular and cell-free inocula have only been established to a very rough approximation. The relative infectiousness of cell-associated and cell-free virus in the semen of HIV-infected men has not been established with sufficient rigor, with particularly few experiments based on the most relevant assays (ie, assays of infectiousness rather than assays of viral DNA and RNA copy numbers). Finally, few experiments have explored the effect of human seminal plasma on transmission efficiency for both cell-associated and cell-free virus.
CONCLUSIONS
First, both the early work with small-animal models and morerecent experiments in multiple primate models have demonstrated that a cell-associated inoculum can mediate vaginal and rectal transmission of HIV and related lentiviruses. Moreover, the inoculum size required for transmission in these models is within the range of infected cells known to be present in the semen of HIV-infected men. Second, the BLT and hu-HSC mouse models have emerged as the preferred small animal systems for studying mucosal transmission by cell-associated (and cell-free) HIV, with greater practicality and relevance to human HIV transmission than either the previously studied cat-FIV or the hu-PBL-SCID models. Third, despite the potential of the lower cost of these models (compared with primate models) to improve the statistical validity of experiments by larger experimental group sizes and robust replication of important experiments, this potential has yet to be fulfilled. Continued improvements in transplant efficiency and increased funding may allow it to be fulfilled it in the future. Fourth, although work with animal models has the potential to investigate the relative importance of cell-associated versus cell-free HIV transmission in humans, this has not yet been accomplished and will require greater quantitative knowledge of the nature of the infectious virus present human semen and much moredetailed transmission dose-response characterizations for both cell-free and cell-associated virus. Finally, small-animal and primate transmission models can play complementary roles in clarifying the many remaining questions about the mechanism of and means to prevent cell-associated transmission of HIV.
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